Skip to main content
SpringerLink
Log in

6. Retroviruskonferenz 1999 in Chicago

Teil II

  • Chapter
Book cover Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz

  • 3 Accesses

Zusammenfassung

Über den geeignetsten Zeitpunkt zum Beginn einer antiretroviralen Behandlung bestehen nach wie vor unterschiedliche Auffassungen. Über die Erfolgsaussichten des ersten Therapieregimes entscheidet die klinisch/virologische Ausgangssituation des Patienten, die Potenz der eingesetzten Medikamentenkombination und nicht zuletzt die Therapieadhärenz des Patienten, die durch gewissenhafte und sorgfältige Aufklärung und Führung durch den Arzt gefördert werden sollte.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 199.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Weiss RA, Wrangham RW (1999) From Pan to pandemic. Nature 397:385–386.

    Article  CAS  PubMed  Google Scholar 

  2. Gao F, Bailest E, Robertson DL, Chen Y, Rodenburg CM, Michael SF, Cummins LB, Arthur LO, Peeters M, Shaw GM, Sharp PM, Hahn BH (1999) Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 397:436–441.

    Article  CAS  PubMed  Google Scholar 

  3. Rich JD, Merriman NA, Mylonakis E, Greenough C, Flanigan TP, Mady BJ, Carpenter CJ (1999) Misdiagnosis of HIV infection by HIV-1 plasma viral load testing: a case series. Annals of Internal Medicine 130:37–39.

    Article  CAS  PubMed  Google Scholar 

  4. Kanki PJ, Hamel DJ, Sankalé JL, Hsieh C, Thior I, Barin F, Woodcock SA, Guèye-Ndiaye A, Zhang E, Montano M, Siby T, Marlink R, Ndoye I, Essex ME, Mboup S (1999) Human immunodeficiency virus type 1 subtypes differ in disease progression. The Journal of Infectious Diseases 179:68–73.

    Article  CAS  PubMed  Google Scholar 

  5. Kaufmann GR, Cunningham P, Kelleher AD, Zaunders J, Carr A, Vizzard J, Law M, Cooper DA, Sydney Primary HIV Infection Study Group (1998) Patterns of viral dynamics during primary human immunodeficiency virus type 1 infection. The Journal of Infectious Diseases 178:1812–1815.

    Article  CAS  PubMed  Google Scholar 

  6. Centers for Disease Control and Prevention CDC (1999) Increases in unsafe sex and rectal Gonorrhea among men who have sex with men — San Francisco, California, 1994–1997. MMWR 48:45–48.

    Google Scholar 

  7. Culnane M, Fowler M, Lee SS, McSherry G, Brady M, O’Donnell K, Mofenson L, Gortmaker SL, Shapiro DE, Scott G, Jimenez E, Moore EC, Diaz C, Flynn PM, Cunningham B, Oleske J (1999) Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. JAMA 281:151–157.

    Article  CAS  PubMed  Google Scholar 

  8. Farzadegan H, Hoover DR, Asternborski J, Lyles CM, Margolick JB, Markham RB, Quinn TC, Vlahov D (1998) Sex differences in HIV-1 viral load and progressiv to AIDS. Lancet 352:1510–1514.

    Article  CAS  PubMed  Google Scholar 

  9. Moore RD, Cheever L, Keruly JC, Chaisson RE (1999) Lack of sex difference in CD4 to HIV-1 RNA viral load ratio. Lancet 353:463–64.

    Article  CAS  PubMed  Google Scholar 

  10. Junghans J, Ledergerber B, Chan P, Weber R, Egger M, Moroni M, on behalf of ICONA Study Group (1999) Sex differences in HIV-1 viral load and progression. (Correspondence) Lancet 353:589.

    CAS  PubMed  Google Scholar 

  11. Webber MP, Schoenbaum EE, Gourevitch MN, Buono D, Klein RS (1999) A prospective study of HIV disease progression in female and male drug users. AIDS 13:257–262.

    Article  CAS  PubMed  Google Scholar 

  12. Gallant JE, Chaisson RE, Keruly JC, Moore RD (1999) Stavudine in zidovudine (ZDV)-experienced compared with ZDV-naive patients. AIDS 13:225–229.

    Article  CAS  PubMed  Google Scholar 

  13. Lorenzi P, Opravil M, Hirschel B, Chave J-P, Furrer H-J, Sax H, Perneger TV, Perrin L, Kaiser L, Yerly S, Swiss HIV Cohort Study (1999) Impact of drug resistance mutations on virologic response to salvage therapy. AIDS 13: F17–F21.

    Article  CAS  PubMed  Google Scholar 

  14. Padberg J, Schürman D, Grobusch M, Bergmann F (1999) Drug interaction of isotretinoin and protease inhibitors: support for the cellular retinoic acid-binding protein-1 theory of lipodystrophy? (Correspondence) AIDS 13:284–85.

    CAS  PubMed  Google Scholar 

  15. Gervasoni C, Ridolfo AL, Trifirò G, Santambrogio S, Norbiato G, Musicco M, Clerici M, Galli M, Moroni M (1999) Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy. AIDS 13:465–471.

    Article  CAS  PubMed  Google Scholar 

  16. Tebas P, Patick AK, Kane EM, Klebert MK, Simpson JH, Erice A, Powderly W, Henry K (1999) Virologic responses to a ritonavir-saquinavir-containing regimen in patients who had previously failed nelfinavir. AIDS 13:F23–F28.

    Article  CAS  PubMed  Google Scholar 

  17. Hellerstein M, Hanley MB, Cesar D, Siler S, Papageorgopoulos C, Wieder E, Schmidt D, Hoh R, Neese R, Macallan D, Deeks S, McCune JM (1999) Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nature Medicine 5:83–89.

    Article  CAS  PubMed  Google Scholar 

  18. Douek DC, McFarland RD, Keiser PH, Gage EA, Massey JM, Haynes BF, Polis MA, Haase AT, Feinberg MB, Sullivan JL, Janieson BD, Zack JA, Picker LJ, Koup RA (1998) Changes in thymic function with age and during the treatment of HIV infection. Nature 396:690–395.

    Article  CAS  PubMed  Google Scholar 

  19. Nielsen SD, Ersbøll AK, Mathiesen L, Nielsen JO, Hansen JES (1998) Highly active antiretroviral therapy normalizes the function of progenitor cells in human immunodeficiency virus-infected patients. The Journal of Infectious Diseases 178:1299–1305.

    Article  CAS  PubMed  Google Scholar 

  20. Merrill DP, Martinez-Picado J, Tremblay C, Sax PE, Boswell SL, Wong JT, D’Aquilla RT, Walker BD, Hirsch S (1999) Improved CD4 lymphocyte outgrowth in response to effective antiretroviral therapy. The Journal of Infectious Diseases 179:345–351.

    Article  CAS  PubMed  Google Scholar 

  21. Greenough TC, Sullivan JL, Desrosiers RC (1999) Declining CD4T-Cell counts in a person infected with nef-delected HIV-1. (Correspondence) The New England Journal of Medicine 340:237.

    Article  Google Scholar 

  22. van Rompay KKA, Dailey PJ, Tarara RP, Canfield DR, Aguirre NL, Cherrington JM, Lamy PD, Bischofberger N, Pedersen NC, Marthas ML (1999) Early short-term 9-[2-(R)-(Phosphonomethoxy)Propyl] Adenine treatment favorably alters the subsequent disease course in simian immunodeficiency virus-infected newborn rhesus macaques. Journal of Virology 73:2947–2955.

    PubMed Central  PubMed  Google Scholar 

  23. Schmitz JE, Kuroda MJ, Santra S, Sasseville VG, Simon MA, Lifton MA, Racz P, Tenner-Racz K, Dalesandro M, Scallon BJ, Ghrayeb J, Forman MA, Montefiori DC, Rieber EP, Letvin NL, Reimann KA (1999) Control of viremia in simian immunodeficiency virus infection by CD8 lymphocytes. Science 283:857–860.

    Article  CAS  PubMed  Google Scholar 

  24. Brodie SJ, Lewinsohn DA, Patterson BK, Jiyamapa D, Krieger J, Corey L, Greenberg PD, Riddell S (1999) In vivo migration and function of transferred HIV-1-specific cytotoxic T cells. Nature Med 5:34–41.

    Article  CAS  PubMed  Google Scholar 

  25. Zajac AJ, Blattman JN, Murali-Krishna K, Sourdive DJD, Suresh M, Altman JD, Ahmed R (1998) Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med 188:2199–2204.

    Article  Google Scholar 

  26. Kalmas SA, Walker BD (1998) The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses. J Exp Med 188:2199–2204.

    Article  Google Scholar 

  27. Steger KK, Waterman PM, Pauza CD (1999) Acute effects of pathogenic simian-human immunodeficiency virus challenge on vaccine-induced cellular and humoral immune responses to gag in rhesus macaques. Journal of Virology 73:1853–1859.

    CAS  PubMed Central  PubMed  Google Scholar 

  28. Johnson RP (1999) Live attenuated AIDS vaccines: hazards and hopes. Nature Medicine 5:154–155.

    Article  CAS  PubMed  Google Scholar 

  29. Baba TW, Liska V, Khimani AH, Ray NB, Dailey PJ, Penninck D, Bronson R, Greene MF, McClure HM, Martin LN, Ruprecht RM (1999) Live attenuated, multiple deleted simian immunodeficiency virus causes AIDS in infant and adult macaques. Nature Medicine 5:194–203.

    Article  CAS  PubMed  Google Scholar 

  30. Berkhout B, Verhoef K, van Wamel JLB, Back NKT (1999) Genetic instability of live, attenuated human immunodeficiendy virus type 1 strains. Journal of Virology 73 (2):1138–1145.

    CAS  PubMed Central  PubMed  Google Scholar 

  31. Cayabyab M, Karlsson GB, Etemad-Moghadam BA, Hofmann W, Steenbeke T, Halloran M, Fanton JW, Axthelm MK, Letvin NL, Sodroski JG (1999) Changes in human immunodeficiency virus type 1 envelope glycoproteins responsible for the pathogenicity of a multiply passaged simian-human immunodeficiency virus (SHIV-HXBc2). Journal of Virology 73 (2): 976–984.

    CAS  PubMed Central  PubMed  Google Scholar 

  32. Lewis MG, Yalley-Ogunro J, Greenhouse JJ, Brennan TP, Bo Jiang J, Van Cott TC, Lu Y, Eddy GA, Birx DL (1999) Limited protection from a pathogenic chimeric simian-human immunodeficiency virus challenge following immunization with attenuated simian immunodeficiency virus. Journal of Virology 73 (2): 1262–1270.

    CAS  PubMed Central  PubMed  Google Scholar 

  33. Joag SV, Qian Liu Z, Stephens EB, Smith MS, Kumar A, Li Z, Wang C, Sheffer D, Jia F, Foresman L, Adany I, Lifson J, McClure HM, Narayan O (1998) Oral immunization of macaques with attenuated vaccine virus induces protection against vaginally transmitted AIDS. Journal of Virology 72(11): 9069–9078.

    CAS  PubMed Central  PubMed  Google Scholar 

  34. Dittmer U, Brooks DM, Hasenkrug KJ (1999) Requirement for multiple lymphocyte subsets in protection by a live attenuated vaccine against retroviral infection. Nature Medicine 5:189–193.

    Article  CAS  PubMed  Google Scholar 

  35. Shibata R, Igarashi T, Haigwood N, Buckler-White A, Ogert R, Ross W, Willey R, Cho MW, Martin MA (1999) Neutralization antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys. Nature Medicine 5:204–216.

    Article  CAS  PubMed  Google Scholar 

  36. Igarashi T, Brown C, Azadegan A, Haigwood N, Dimitrov D, Martin MA, Shibata R (1999) Human immunodeficiency virus type 1 neutralizing antibodies accelerate clearance of cell-free virions from blood plasma. Nature Medicine 5:211–216.

    Article  CAS  PubMed  Google Scholar 

  37. Moore JP, Burton DR (1999) HIV-1 neutralizing antibodies: How full is the bottle? Nature Medicine 5:142–144.

    Article  CAS  PubMed  Google Scholar 

  38. LaCasse RA, Follis KE, Trahey M, Scarborough JD, Littman DR, Nunberg JH (1999) Fusion-competent vaccines: Broad neutralization of primary isolates of HIV. Science 283:357–362.

    Article  CAS  PubMed  Google Scholar 

  39. Montefiori DC, Moore JP (1999) Magic of the occult? Science 283:336–337.

    Article  CAS  PubMed  Google Scholar 

  40. Gallo RC (1998) The enigmas of Kaposi’s Sarcoma. Science 282:1837–1839.

    Article  CAS  PubMed  Google Scholar 

  41. LaDuca JR, Love L, Abbott LZ, Dube S, Freidman-Kien AE, Poiesz BJ (1998) Detection of Human Herpesvirus 8 DNA sequences in tissues and bodily fluids. The Journal of Infectious Diseases 178:1610–1615.

    Article  CAS  PubMed  Google Scholar 

  42. Blackbourn DJ, Osmond D, Levy JA, Lennette ET (1999) Increased Human Herpesvirus 8 seroprevalence in young homosexual men who have multiple sex contacts with different partners. The Journal of Infectious Diseases 179:237–239.

    Article  CAS  PubMed  Google Scholar 

  43. He J, Bhat G, Kankasa C, Chintu C, Mitchell C, Duan W, Wood C (1998) Seroprevalence of Human Herpesvirus 8 among Zambian women of childbearing age without Kaposi’s Sarcoma (KS) and mother-child pairs with KS. The Journal of Infectious Diseases 178:1787–1790.

    Article  CAS  PubMed  Google Scholar 

  44. Whitby D, Smith NA, Matthews S, O’Shea S, Sabin CA, Kulasegaram R, Boshoff C, Weiss RA, de Ruiter A, Best JM (1999) Human herpesvirus 8: seroepidemiology among women and detection in the genital tract of seropositive women. The Journal of Infectious Diseases 179:234–236.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Robert Koch-Institut, Nordufer 20, D-13353, Berlin, Deutschland

    Dr. Ulrich Marcus

Authors
  1. Dr. Ulrich Marcus
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Marcus, U. (1999). 6. Retroviruskonferenz 1999 in Chicago. In: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-38283-7_82

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-38283-7_82

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-37515-0

  • Online ISBN: 978-3-662-38283-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation